{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:18:30Z","timestamp":1788236310570,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmcl.2024.129928","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T16:37:43Z","timestamp":1723653463000},"page":"129928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis and biological evaluation of novel aminoquinolines with an n-octyl linker: Impact of halogen substituents on C(7) or a terminal amino group on anticholinesterase and BACE1 activity"],"prefix":"10.1016","volume":"112","author":[{"given":"Ana","family":"Mato\u0161evi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Bartoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Marakovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Zandona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajo","family":"Petri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Opsenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129928_b0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fnagi.2019.00317","article-title":"Dreaming of a new world where Alzheimer\u2019s is a treatable disorder","volume":"11","author":"Catania","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmcl.2024.129928_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JAD-179921","article-title":"Multifactorial hypothesis and multi-targets for Alzheimer\u2019s disease","volume":"64","author":"Gong","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bmcl.2024.129928_b0015","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"da Silva Hage-Melim LI. Alzheimer\u2019s disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment","volume":"23","author":"dos Santos Pican\u00e7oa","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1570159X14666151208112754","article-title":"Current treatment options for Alzheimer\u2019s disease and Parkinson\u2019s disease dementia","volume":"14","author":"Szeto","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.bmcl.2024.129928_b0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bmcl.2024.129928_b0030","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2174\/0929867325666180111101843","article-title":"Multi-target directed drugs as a modern approach for drug design towards Alzheimer\u2019s disease: an update","volume":"25","author":"de Freitas","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","article-title":"A molecular approach in drug development for Alzheimer\u2019s disease","volume":"106","author":"Agatonovic-Kustrin","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2024.129928_b0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/molecules21040466","article-title":"Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer\u2019s disease","volume":"21","author":"Prati","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.129928_b0045","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0050","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17460441.2019.1623201","article-title":"Developments with multi-target drugs for Alzheimer\u2019s disease: an overview of the current discovery approaches","volume":"14","author":"Gonz\u00e1lez","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2024.129928_b0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/pharmaceutics14061305","article-title":"4-aminoquinoline-based adamantanes as potential anticholinesterase agents in symptomatic treatment of Alzheimer\u2019s disease","volume":"14","author":"Komatovi\u0107","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2024.129928_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2019.05.024","article-title":"Structural aspects of 4- aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase","volume":"308","author":"Bosak","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2024.129928_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110620","article-title":"Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer\u2019s disease","volume":"382","author":"Mato\u0161evi\u0107","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2024.129928_b0070","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Flourine and fluorinated motifs in the design and application of bioisosters for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0075","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/17460441.2021.1933427","article-title":"Applications of fluorine to the construction of bioisosteric elements for the purposres of novel drug discovery","volume":"16","author":"Richardson","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2024.129928_b0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0960-894X(00)80545-4","article-title":"The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex) derivatives","volume":"2","author":"Gregor","year":"1992","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2024.129928_b0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bioorg.2019.02.033","article-title":"Chlorinated tacrine analogs: design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer\u2019s disease","volume":"86","author":"Raagab","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acschembio.6b01149","article-title":"Long-chained 4-aminoquinolines as quorum sensing inhibitors in Serratia marcescens and Pseudomonas aeruginosa","volume":"12","author":"Aleksi\u0107","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2024.129928_b0095","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1021\/acschembio.9b00682","article-title":"N-benzyl derivatives of long-chained 4-amino-7-chloro-quionolines as inhibitors of pyocyanin production in Pseudomonas aeruginosa","volume":"14","author":"Aleksic","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2024.129928_b0100","first-page":"173","article-title":"Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by ethopropazine","volume":"74","author":"Simeon-Rudolf","year":"2001","journal-title":"Croat Chem Acta"},{"key":"10.1016\/j.bmcl.2024.129928_b0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"New and rapid colorimetric determination of acetylcho-linesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129928_b0110","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0115","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2024.129928_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00204-020-02811-5","article-title":"Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers","volume":"94","author":"Zandona","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.bmcl.2024.129928_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(02)00004-2","article-title":"Prediction of intestinal permeability","volume":"54","author":"Egan","year":"2002","journal-title":"Adv Drug Deliv Rev."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T21:42:46Z","timestamp":1726350166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"alternative-id":["S0960894X24003305"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129928","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel aminoquinolines with an n-octyl linker: Impact of halogen substituents on C(7) or a terminal amino group on anticholinesterase and BACE1 activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129928"}}